Value and difficulties of a common European strategy for recurrent Wilms' tumor

Expert Rev Anticancer Ther. 2009 Jun;9(6):693-6. doi: 10.1586/era.09.45.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Child
  • Clinical Trials as Topic
  • Europe / epidemiology
  • Humans
  • International Cooperation*
  • Neoplasm Recurrence, Local
  • Risk Factors
  • Salvage Therapy / methods
  • Survival Rate
  • Treatment Outcome
  • Wilms Tumor / mortality
  • Wilms Tumor / physiopathology
  • Wilms Tumor / therapy*